PLATINUM Diversity: Outcomes With the Promus PREMIER Stent in Women and Minorities (S2326)

Trial Profile

PLATINUM Diversity: Outcomes With the Promus PREMIER Stent in Women and Minorities (S2326)

Completed
Phase of Trial: Phase IV

Latest Information Update: 19 May 2017

At a glance

  • Drugs Everolimus (Primary)
  • Indications Coronary artery disease; Coronary artery restenosis
  • Focus Therapeutic Use
  • Acronyms PLATINUM Diversity
  • Sponsors Boston Scientific Corporation
  • Most Recent Events

    • 19 May 2017 According to a Boston Scientific Corporation media release, New data from this study was presented at the 40th Annual Society for Cardiac Angiography and Interventions (SCAI) Scientific Sessions.
    • 07 Mar 2017 Last checked against ClinicalTrials.gov record.
    • 02 Mar 2017 Status changed from active, no longer recruiting to completed.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top